NuShores Biosciences LLC will receive nearly half a million dollars to be added to their current 3-year contract awarded through the Medical Technology Enterprise Consortium (MTEC)
NuShores Biosciences receives commercialization program funding for NuCressâ„¢ bone filler scaffolds
NuShores Biosciences LLC has been awarded a $50,000 grant from Medical Technology Enterprise Consortium
Sam Monk — a seasoned medical device professional — will help to lead NuShores’ quality and regulatory efforts for NuCressâ„¢ […]
By Sharon Ballard, Little Rock, AR NuShores Biosciences LLC has been awarded a 3-year, $2.9M commercialization readiness grant from the […]
NuShores Biosciences LLC has won a 3-year, $2.8M contract from the Medical Technology Enterprise Consortium (MTEC), a 501(c)(3) biomedical technology consortium associated with the U.S. Army Medical Research and Development Command.
UA Little Rock has received Army Medical Command approval to contract with NuShores to perform first generation production development of the NuCressTM bone regenerative product line.
Mark Pelo will lead NuShores’ production of NuCress™ bone regenerative product line.
By Sharon Ballard Little Rock, AR – NuShores Biosciences LLC (NuShores), founded and based in Little Rock, Arkansas, announced today […]
The Homeland Defense and Security Information Analysis Center (HDIAC) features the NuCress Bone Regeneration Scaffold in their TechTalk channel. See […]
Source: Rebecca Todd, Arkansas Small Business and Technology Development Center http://asbtdc.org/ua-little-rock-spinout-nushores-biosciences-receives-sbir-matching-grant/
They’ve Said About US
-
I am honored to serve on the advisory board for NuShores Biosciences LLC. I look forward to opportunities to contribute to your efforts with my experience and lessons learned in the areas of science – technology planning and commercialization, and to assist in the clinical aspects to make it available to patients as soon as possible.
-
The NuShores group has assembled a very strong development team under Dr. Biris and the operational depth needed to bring their novel materials to the market. I am very excited to be contributing to NuShores and Alex’ team.
-
I am delighted to be working with such a wonderful team on lifechanging technologies and applications. It is an honor to be along for the journey.
-
It is a rare opportunity to be able to support the historic scientific discoveries licensed to NuShores from UA Little Rock that will have a significant positive impact on public health and clinical practices. Â I am blessed to be able to participate with NuShores team in maturing such scientific breakthroughs to commercial success
-
I am very excited to work with the team at NuShores in the development of an enabling technology in tissue regeneration. I have worked with the group for some time now and have the greatest respect for their approach to the challenge and the quality of their research. I believe that the rigor behind their work is world class and will be regarded as a new standard of care in repairing bone loss.
-
The opportunity to serve on the board of NuShores is exciting and thought-provoking. As an active member of the scientific community with a specific interest in orthopedics, the ongoing research is especially relevant and exciting for me.  I am delighted to have to opportunity to help such a robust and creative group move their technology and research efforts forward
-
I am pleased to serve on the NuShores’ Advisory Board and look forward to contributing to their venture’s product successes. There is a need for their innovative NuCress™ bone void filler that has potential use in my areas of medical practice. I look forward to working with the NuShores team in accomplishing the scientific, regulatory and development milestones to make such a product available to physicians and their patients
